New: NCI-funded clinical trial search
Mednet Logo

How are you modifying your current sarcoma-directed therapy in the setting of the COVID-19 pandemic?

For example, would you consider switching to an outpatient regimen in lieu of AIM for metastatic soft tissue sarcoma?
1 Answer
Mednet MemberInvited Expert
Radiation Oncology · Fox Chase Cancer Center
Answered on · Updated on

Here are the guidelines at Fox Chase Cancer Center by Margaret von Mehren MD, @Dr. First Last , Jeffrey Farma MD, Sanjay Reddy MD, John Abraham, MD, and Stephanie Greco, MD

I. Management of STS during COVID-19 Pandemic:

During the current pandemic, care will need to be changed to allow for hospitals/treating facilities to prioritize resources for those who are critically ill with the virus as well as those caring for them. In addition, patient care should be assessed and managed to decrease risk for contracting COVID-19.

General Principles include:

  1. Delaying surgery to preserve resources
  2. Any bone involvement, particularly lower extremity or metastatic disease with intermediate or high risk of fracture should still be stated as being consi...

Join for free or sign in to see the full answer